Financials
- Market Capitalization 6.77 M
- Employee 5
- Founded 2022
- CEO N/A
- Website www.cadrenal.com
- Headquarter Delaware, United States
- FIGI BBG019STRT20
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.02
ratio cours/chiffre d'affaires
—
Dividende par action
16.5
Rendement du dividende (%)
243.36
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4901 | ERNA Ernexa Therapeutics Inc. - Common Stock | 6.11 USD | +10.29% | -8.12% | -6.86% | +1648.21% | 7.13 M USD | ||
| 4904 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 4.80 USD | -5.70% | -5.51% | +0.21% | +451.72% | 7.01 M USD | ||
| 4913 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.56 USD | -1.27% | +8.33% | -3.70% | -18.75% | 6.70 M USD | ||
| 4917 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.81 USD | -2.43% | -4.42% | +21.65% | +212.92% | 6.65 M USD |